Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature

Dahlin, 1967, Osteogenic sarcoma. A study of 600 cases, J Bone Joint Surg, 49A, 101, 10.2106/00004623-196749010-00008

Huvos, 1991

Bridge, 1993, Cytogenetics and molecular cytogenetic techniques in orthopaedic surgery, Curr Concepts Rev; J Bone Joint Surg, 75A, 606, 10.2106/00004623-199304000-00017

Sandberg, 1994

Bridge, 1996, Cytogenetics and experimental models of sarcomas, 284

Bridge, 1996, Cytogenetics of soft tissue tumors, Cancer J, 9, 129

Bridge JA, Örndal C (in press): Cytogenetic analysis of bone and joint neoplasms. In: Pathology of Bone and Joint Neoplasms. T Helliwell, ed. W.B. Saunders Co., Orlando.

Sinovic, 1992, Ring chromosome in parosteal osteosarcoma. Clinical and diagnostic significance, Cancer Genet Cytogenet, 62, 50, 10.1016/0165-4608(92)90038-A

Pfeifer, 1991, Cytogenetic findings in aneurysmal bone cysts, Genes Chromosom Cancer, 3, 416, 10.1002/gcc.2870030603

Kurt, 1990, Lowgrade intraosseous osteosarcoma, Cancer, 65, 1418, 10.1002/1097-0142(19900315)65:6<1418::AID-CNCR2820650629>3.0.CO;2-Q

ISCN, 1995, An International System for Human Cytogenetic Nomenclature

Castedo, 1988, Cytogenetics of a case of osteosarcoma, Cancer Genet Cytogenet, 32, 149, 10.1016/0165-4608(88)90322-6

Pearson, 1988, Cytogenetic investigations of solid tumours of children, Arch Dis Child, 63, 1012, 10.1136/adc.63.9.1012

Biegel, 1989, Complex karyotypes in a series of pediatric osteosarcomas, Cancer Genet Cytogenet, 38, 89, 10.1016/0165-4608(89)90169-6

Tarkkanen, 1993, Cytogenetic study of 249 consecutive patients examined for a bone tumor, Cancer Genet Cytogenet, 68, 1, 10.1016/0165-4608(93)90068-W

Mertens, 1993, Cytogenetic findings in 33 osteosarcomas, Int J Cancer, 55, 44, 10.1002/ijc.2910550109

Schwartz, 1992, Cytogenetic abnormalities in a rare case of giant cell osteogenic sarcoma, Cancer Genet Cytogenet, 58, 60, 10.1016/0165-4608(92)90135-U

Ozisik, 1993, Deletion of chromosome 13 in osteosarcoma secondary to irradiation, Cancer Genet Cytogenet, 69, 335, 10.1016/0165-4608(93)90109-Y

Ozisik, 1994, Cytogenetic findings in 19 malignant bone tumors, Cancer, 74, 2268, 10.1002/1097-0142(19941015)74:8<2268::AID-CNCR2820740810>3.0.CO;2-5

Fletcher, 1994, Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings and double-minute chromosomes, Cancer Genet Cytogenet, 77, 81, 10.1016/0165-4608(94)90154-6

Hoogerwerf, 1994, Chromosome analysis of nine osteosarcomas, Genes Chromosom Cancer, 9, 88, 10.1002/gcc.2870090203

Bridge, 1993, Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions, Cancer Genet Cytogenet, 69, 79, 10.1016/0165-4608(93)90080-6

Toguchida, 1989, Assignment of common allele loss in osteosarcoma to the subregion 17p13, Cancer Res, 49, 6247

Miller, 1990, Frequency and structure of p53 rearrangements in human osteosarcoma, Cancer Res, 50, 7950

Toguchida, 1992, Mutation spectrum of the p53 gene in bone and soft tissue sarcomas, Cancer Res, 52, 6194

Malkin, 1990, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms, Science, 250, 1233, 10.1126/science.1978757

Dryja, 1986, Chromosome 13 homozygosity in osteosarcoma without retinoblastoma, Am J Hum Genet, 38, 59

Wadayama, 1994, Mutation spectrum of the retinoblastoma gene in osteosarcomas, Cancer Res, 54, 3042

Heim, 1995

Tarkkanen, 1995, Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization, Cancer Res, 55, 1334

Ladanyi, 1993, MDM2 gene amplification in metastatic osteosarcoma, Cancer Res, 53, 16

Oliner, 1992, Amplification of a gene encoding a p53-associated protein in human sarcomas, Nature, 358, 80, 10.1038/358080a0

Khatib, 1993, Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas, Cancer Res, 53, 5535

Roberts, 1989, Amplification of the gli gene in childhood sarcomas, Cancer Res, 49, 5407

Forus, 1995, Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas, Genes Chromosom Cancer, 14, 15, 10.1002/gcc.2870140104

1991, Cytogenet Cell Genet, 58, 1161

Craig, 1992, Report of the first international workshop on human chromosome 12 mapping, Cytogenet Cell Genet, 61, 243, 10.1159/000133416

Jansson, 1990, An immunohistochemical analysis of ras oncogene expression in epithelial neoplasms of the colon, Cancer, 65, 1329, 10.1002/1097-0142(19900315)65:6<1329::AID-CNCR2820650614>3.0.CO;2-4

Bland, 1995, Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos and p53 as prognostic discriminants for breast carcinoma, Ann Surg, 221, 706, 10.1097/00000658-199506000-00010

Motojima, 1993, Detection of point mutations in the Kirstenras oncogene provides evidence for the multicentricity of pancreatic carcinoma, Ann Surg, 217, 138, 10.1097/00000658-199302000-00007

Konishi, 1992, K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men, Cancer, 69, 2293, 10.1002/1097-0142(19920501)69:9<2293::AID-CNCR2820690915>3.0.CO;2-O

Harada, 1992, Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer, Cancer, 69, 72, 10.1002/1097-0142(19920101)69:1<72::AID-CNCR2820690114>3.0.CO;2-A

Barrios, 1993, Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma, J Ortho Res, 11, 556, 10.1002/jor.1100110410

Cui, 1991, Mutational activation of K-ras gene is absent in human osteosarcoma, Med Sci Res, 19, 697

Antillon-Klussmann, 1995, Mutational activation of ras genes is absent in pediatric osteosarcoma, Cancer Genet Cytogenet, 79, 49, 10.1016/0165-4608(94)00115-R

Bridge, 1992, Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature, Cancer Genet Cytogenet, 58, 2, 10.1016/0165-4608(92)90125-R

McComb, 1996, Chromosomal anomalies exclusive of telomeric associations in giant cell tumor of bone, Cancer Genet Cytogenet, 88, 163, 10.1016/0165-4608(95)00362-2

Sciot, 1995, Giant cell rich parosteal osteosarcoma, Histopathology, 27, 51, 10.1111/j.1365-2559.1995.tb00290.x

Hatada, 1992, The ankyrin repeat domains of the NF-kβ precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kβ DNA binding, 89, 2489

Fujii, 1986, Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7, Som Cell Mol Genet, 12, 281, 10.1007/BF01570787

Bridge, 1991, Cytogenetics of 226 bone lesions: Pathogenetic, diagnostic and clinical relevance, Am J Hum Genet, 49, 239

Szymanska, 1996, Ring chromosomes in parosteal osteosarcoma gcontain sequences from 12813-15: A combined cyto genetic and comparative genomic hybridization study, Genes Chromosom Cancer, 16, 31, 10.1002/(SICI)1098-2264(199605)16:1<31::AID-GCC4>3.0.CO;2-4